Cross Country Healthcare

Forecast & Rating9 analysts currently cover Cross Country Healthcare, with about 0.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $12.60, about 4.9% downside from the current price of $13.25. Price targets span a fair range, indicating some disagreement among institutions. Historically, about 63.4% of past price targets were eventually met, which adds credibility. For you, this means most institutions are cautious on Cross Country Healthcare's outlook. Data as of Jul 21, 2026; for reference only and not investment advice.